Find AMXT-1501 dicaprate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: T9gpe23kz9, Chembl6068506, 2135609-32-2, Decanoic acid, compd. with n-[(5r)-5-amino-6-[[3-[[4-[(3-aminopropyl)amino]butyl]amino]propyl]amino]-6-oxohexyl]hexadecanamide (2:1)
Molecular Formula
C52H108N6O6
Molecular Weight
913.5  g/mol
InChI Key
PMQBHPUZUKOTJJ-ZHXNKHNVSA-N
FDA UNII
T9GPE23KZ9

AMXT-1501 dicaprate
Polyamine Transport Inhibitor AMXT-1501 Dicaprate is the dicaprate salt form of AMXT-1501, an orally bioavailable polyamine transport inhibitor, with immunostimulating and antineoplastic activities. Upon administration, AMXT-1501 targets, binds to and blocks polyamine transport from the bloodstream into the tumor microenvironment (TME), thereby preventing cancer cell uptake. This decreases polyamine concentrations inside the TME and tumor cell, inhibits tumor cell proliferation and induces apoptosis. In addition, AMXT-1501 may abrogate polyamine-mediated immune suppression in the TME. Polyamines, naturally found in normal, heathy cells, are required for normal cell growth and division. In cancer cells, polyamines play key roles in tumor cell proliferation and tumor-induced suppression of the patient's immune system.
1 2D Structure

AMXT-1501 dicaprate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[(5R)-5-amino-6-[3-[4-(3-aminopropylamino)butylamino]propylamino]-6-oxohexyl]hexadecanamide;bis(decanoic acid)
2.1.2 InChI
InChI=1S/C32H68N6O2.2C10H20O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-22-31(39)37-28-16-15-21-30(34)32(40)38-29-20-27-36-25-18-17-24-35-26-19-23-33;2*1-2-3-4-5-6-7-8-9-10(11)12/h30,35-36H,2-29,33-34H2,1H3,(H,37,39)(H,38,40);2*2-9H2,1H3,(H,11,12)/t30-;;/m1../s1
2.1.3 InChI Key
PMQBHPUZUKOTJJ-ZHXNKHNVSA-N
2.2 Other Identifiers
2.2.1 UNII
T9GPE23KZ9
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. T9gpe23kz9

2. Chembl6068506

3. 2135609-32-2

4. Decanoic Acid, Compd. With N-[(5r)-5-amino-6-[[3-[[4-[(3-aminopropyl)amino]butyl]amino]propyl]amino]-6-oxohexyl]hexadecanamide (2:1)

2.4 Create Date
2024-01-03
3 Chemical and Physical Properties
Molecular Weight 913.5 g/mol
Molecular Formula C52H108N6O6
Hydrogen Bond Donor Count8
Hydrogen Bond Acceptor Count10
Rotatable Bond Count48
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area209
Heavy Atom Count64
Formal Charge0
Complexity660
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty